Yilifang Biotech.
Shenzhen Yilifang Biotechn≤₽★‌ology Co., Ltd. was e>∏πstablished in 2013. It is a ↔✘®national high-tech enterprise integrating the dδ±​evelopment, production and sales of precision meφα"☆dical in vitro diagnostic reagents. ¥♠&The companychr(34)s research and development ®φλteam consist of scientific researc≤ λ♦hers from top international institut©ε∑ions and domestic translation medical©♠γ✔ elites, including hi☆↔gh-quality talents of national leading ta£≈ ↕lents, Class B peacock talents, and r÷™∞"eserve talents. Targeting exi← •sting "pain points" in the market$ →‍, Yilifang links with domestic≈​&​ and foreign cutting-edge technologies and commσ☆™itted to creating good products that can tr§δuly address the demands form the mar★φket.

Product architecture
From the major disea≥↓€ses that the society needs to sol∑¥←÷ve urgently, Yilifang ♦∞γhas built products in four major≥≈β sectors. It has successfully developed  ↑more than 20 Class III in vitro diagno₽★stic products, and its products have ¥♦→gradually entered the national♣←↔ registration stage.

Yilifang was established in≠€↓α the new era of precision medic σine. Since its inception, Yilifang has been pr‌™agmatic and prudent in its work style. It has v₽¥igorously coordinate₩‍↔βd development in talent ®♣cultivation, research and development iεσnnovation, safety compliance, and quality syste ✘ πm construction, etc. It has also mad¶♠ 'e initial achievements. In terms of talen>Ωt training, a high-quality elite team ha♥→s been created. Among the current me£♥¶δmbers, about 50% of empl←÷≈oyees have masterchr("¥34)s degrees, and more than 10% ha">←πve doctoral degrees. A÷"∏ platform, a post-doctoral practice and innovati' on base, for sustainably me ¶ eting the needs of h‍β≠igh-end talents-a postdoctoral practice€α innovation base has been establi<αshed. On the other hand, Yilifang adheres ♦→<to the idea of quality as the ≠₹✘★basis and regulations as the norm, a'÷¥ nd has established a comprehensive system in te✘σ€®rms of quality and safety, fire safe∞♠λty and environmental protection. In terms o<✘∞​f technological innovation,​↓∑ Yilifang has obtained national, provincial,δ→≤ and municipal department’ rec↕∏ognition and awards at various level≈≥$™s through independent research and developmen₽₩‍t. In 2017, as the only represent&β≤ative of the Shenzhen In vitro Diagnostic Rea<≥gent Enterprise Group, it was promoted to t'≥¥<he National Innovation and Entrepreβ∏neurship Competition.